Serveur d'exploration Chloroquine

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Sprouty2 downregulation plays a pivotal role in mediating crosstalk between TGF‐β1 signaling and EGF as well as FGF receptor tyrosine kinase‐ERK pathways in mesenchymal cells

Identifieur interne : 001A99 ( Main/Exploration ); précédent : 001A98; suivant : 001B00

Sprouty2 downregulation plays a pivotal role in mediating crosstalk between TGF‐β1 signaling and EGF as well as FGF receptor tyrosine kinase‐ERK pathways in mesenchymal cells

Auteurs : Wei Ding [États-Unis] ; Wei Shi [États-Unis] ; Saverio Bellusci [États-Unis] ; John Groffen [États-Unis] ; Nora Heisterkamp [États-Unis] ; Parviz Minoo [États-Unis] ; David Warburton [États-Unis]

Source :

RBID : ISTEX:65538A0A8C504C9FFED9A73A517B79281A888132

English descriptors

Abstract

Mammalian Sprouty2 (Spry2) is a key regulator of the receptor tyrosine kinase/ERK signaling pathway and is involved in many biological processes, including cell growth, differentiation, migration, and embryonic lung branching morphogenesis. Previous studies have shown that Spry2 expression is upregulated by many mitogens, particularly epidermal growth factor (EGF) and fibroblast growth factors (FGFs). In contrast, we report that transforming growth factor‐β1 (TGF‐β1), which stimulates the growth of quiescent Swiss 3T3 cells, induced a dose dependent decrease of mouse Spry2 protein level within 24‐h of treatment, and this effect was mediated by a MAP kinase‐independent pathway. A concomitant reduction of the level of Spry2 mRNA indicates the involvement of a transcriptional mechanism, which requires histone deacetylase (HDAC) activity and de novo protein synthesis. On the other hand, the turnover rate of Spry2 protein was increased by TGF‐β1 treatment, suggesting enhanced Spry2 degradation. Treatment with lysosomal inhibitors, but not proteasome inhibitors, prevented the degradation of Spry2, thus, indicating that the degradation of Spry2 is mediated through the lysosomal pathway in Swiss 3T3 cells. Furthermore, we demonstrate that TGF‐β1 signaling can modulate EGF and FGF‐induced ERK‐MAP kinase activation by controlling Spry2 expression and function. Moreover, rescue of the TGF‐β1‐induced downregulation of Spry2 by gene over‐expression led to inhibition of the mitogenic effect of TGF‐β1 in Swiss 3T3 cells. Together, the combined operation of transcriptional and post‐translational mechanisms suggests that regulation of Spry2 is a crucial event and emphasizes the important role that Spry2 plays in controlling cell behaviors. J. Cell. Physiol. 212:796–806, 2007. © 2007 Wiley‐Liss, Inc.

Url:
DOI: 10.1002/jcp.21078


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI wicri:istexFullTextTei="biblStruct">
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Sprouty2 downregulation plays a pivotal role in mediating crosstalk between TGF‐β1 signaling and EGF as well as FGF receptor tyrosine kinase‐ERK pathways in mesenchymal cells</title>
<author>
<name sortKey="Ding, Wei" sort="Ding, Wei" uniqKey="Ding W" first="Wei" last="Ding">Wei Ding</name>
</author>
<author>
<name sortKey="Shi, Wei" sort="Shi, Wei" uniqKey="Shi W" first="Wei" last="Shi">Wei Shi</name>
</author>
<author>
<name sortKey="Bellusci, Saverio" sort="Bellusci, Saverio" uniqKey="Bellusci S" first="Saverio" last="Bellusci">Saverio Bellusci</name>
</author>
<author>
<name sortKey="Groffen, John" sort="Groffen, John" uniqKey="Groffen J" first="John" last="Groffen">John Groffen</name>
</author>
<author>
<name sortKey="Heisterkamp, Nora" sort="Heisterkamp, Nora" uniqKey="Heisterkamp N" first="Nora" last="Heisterkamp">Nora Heisterkamp</name>
</author>
<author>
<name sortKey="Minoo, Parviz" sort="Minoo, Parviz" uniqKey="Minoo P" first="Parviz" last="Minoo">Parviz Minoo</name>
</author>
<author>
<name sortKey="Warburton, David" sort="Warburton, David" uniqKey="Warburton D" first="David" last="Warburton">David Warburton</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:65538A0A8C504C9FFED9A73A517B79281A888132</idno>
<date when="2007" year="2007">2007</date>
<idno type="doi">10.1002/jcp.21078</idno>
<idno type="url">https://api.istex.fr/ark:/67375/WNG-0Z28WS1L-4/fulltext.pdf</idno>
<idno type="wicri:Area/Istex/Corpus">002C83</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">002C83</idno>
<idno type="wicri:Area/Istex/Curation">002C83</idno>
<idno type="wicri:Area/Istex/Checkpoint">000982</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">000982</idno>
<idno type="wicri:doubleKey">0021-9541:2007:Ding W:sprouty:downregulation:plays</idno>
<idno type="wicri:Area/Main/Merge">001B10</idno>
<idno type="wicri:Area/Main/Curation">001A99</idno>
<idno type="wicri:Area/Main/Exploration">001A99</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title level="a" type="main">Sprouty2 downregulation plays a pivotal role in mediating crosstalk between TGF‐β1 signaling and EGF as well as FGF receptor tyrosine kinase‐ERK pathways in mesenchymal cells</title>
<author>
<name sortKey="Ding, Wei" sort="Ding, Wei" uniqKey="Ding W" first="Wei" last="Ding">Wei Ding</name>
<affiliation wicri:level="2">
<country>États-Unis</country>
<placeName>
<region type="state">Californie</region>
</placeName>
<wicri:cityArea>Developmental Biology Program, Childrens Hospital Los Angeles Saban Research Institute, Los Angeles</wicri:cityArea>
</affiliation>
<affiliation wicri:level="1">
<country wicri:rule="url">États-Unis</country>
</affiliation>
<affiliation wicri:level="2">
<country xml:lang="fr">États-Unis</country>
<placeName>
<region type="state">Californie</region>
</placeName>
<wicri:cityArea>Correspondence address: Developmental Biology Program, Childrens Hospital Los Angeles Saban Research Institute, 4650 Sunset Blvd., MS 35, Los Angeles</wicri:cityArea>
</affiliation>
</author>
<author>
<name sortKey="Shi, Wei" sort="Shi, Wei" uniqKey="Shi W" first="Wei" last="Shi">Wei Shi</name>
<affiliation wicri:level="2">
<country>États-Unis</country>
<placeName>
<region type="state">Californie</region>
</placeName>
<wicri:cityArea>Developmental Biology Program, Childrens Hospital Los Angeles Saban Research Institute, Los Angeles</wicri:cityArea>
</affiliation>
</author>
<author>
<name sortKey="Bellusci, Saverio" sort="Bellusci, Saverio" uniqKey="Bellusci S" first="Saverio" last="Bellusci">Saverio Bellusci</name>
<affiliation wicri:level="2">
<country>États-Unis</country>
<placeName>
<region type="state">Californie</region>
</placeName>
<wicri:cityArea>Developmental Biology Program, Childrens Hospital Los Angeles Saban Research Institute, Los Angeles</wicri:cityArea>
</affiliation>
</author>
<author>
<name sortKey="Groffen, John" sort="Groffen, John" uniqKey="Groffen J" first="John" last="Groffen">John Groffen</name>
<affiliation wicri:level="2">
<country>États-Unis</country>
<placeName>
<region type="state">Californie</region>
</placeName>
<wicri:cityArea>Division of Hematology/Oncology, Childrens Hospital of Los Angeles Saban Research Institute, Los Angeles</wicri:cityArea>
</affiliation>
</author>
<author>
<name sortKey="Heisterkamp, Nora" sort="Heisterkamp, Nora" uniqKey="Heisterkamp N" first="Nora" last="Heisterkamp">Nora Heisterkamp</name>
<affiliation wicri:level="2">
<country>États-Unis</country>
<placeName>
<region type="state">Californie</region>
</placeName>
<wicri:cityArea>Division of Hematology/Oncology, Childrens Hospital of Los Angeles Saban Research Institute, Los Angeles</wicri:cityArea>
</affiliation>
</author>
<author>
<name sortKey="Minoo, Parviz" sort="Minoo, Parviz" uniqKey="Minoo P" first="Parviz" last="Minoo">Parviz Minoo</name>
<affiliation wicri:level="2">
<country>États-Unis</country>
<placeName>
<region type="state">Californie</region>
</placeName>
<wicri:cityArea>Department of Pediatrics, USC Keck School of Medicine, Los Angeles</wicri:cityArea>
</affiliation>
</author>
<author>
<name sortKey="Warburton, David" sort="Warburton, David" uniqKey="Warburton D" first="David" last="Warburton">David Warburton</name>
<affiliation wicri:level="2">
<country>États-Unis</country>
<placeName>
<region type="state">Californie</region>
</placeName>
<wicri:cityArea>Developmental Biology Program, Childrens Hospital Los Angeles Saban Research Institute, Los Angeles</wicri:cityArea>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series>
<title level="j" type="main">Journal of Cellular Physiology</title>
<title level="j" type="alt">JOURNAL OF CELLULAR PHYSIOLOGY</title>
<idno type="ISSN">0021-9541</idno>
<idno type="eISSN">1097-4652</idno>
<imprint>
<biblScope unit="vol">212</biblScope>
<biblScope unit="issue">3</biblScope>
<biblScope unit="page" from="796">796</biblScope>
<biblScope unit="page" to="806">806</biblScope>
<biblScope unit="page-count">11</biblScope>
<publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher>
<pubPlace>Hoboken</pubPlace>
<date type="published" when="2007-09">2007-09</date>
</imprint>
<idno type="ISSN">0021-9541</idno>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt>
<idno type="ISSN">0021-9541</idno>
</seriesStmt>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="Teeft" xml:lang="en">
<term>Actinomycin</term>
<term>Biol</term>
<term>Biol chem</term>
<term>Cell growth</term>
<term>Cell proliferation</term>
<term>Cellular physiology</term>
<term>Chem</term>
<term>Childrens hospital</term>
<term>Degradation</term>
<term>Downregulates</term>
<term>Downregulation</term>
<term>Drosophila</term>
<term>Dspry</term>
<term>Egfr</term>
<term>Egfr ubiquitination</term>
<term>Endogenous</term>
<term>Endogenous spry2</term>
<term>Growth factor</term>
<term>Hdac</term>
<term>Immunoblotting</term>
<term>Inhibitor</term>
<term>Inhibitory effect</term>
<term>Kinase</term>
<term>Lysosomal</term>
<term>Lysosomal inhibitors</term>
<term>Mapk</term>
<term>Mesenchymal cells</term>
<term>Mitogenic</term>
<term>Mitogenic effect</term>
<term>Mrna</term>
<term>Nh4cl</term>
<term>Pathway</term>
<term>Pretreated</term>
<term>Proteasome</term>
<term>Protein synthesis</term>
<term>Receptor</term>
<term>Recombinant spry2</term>
<term>Smad</term>
<term>Smad pathway</term>
<term>Smad proteins</term>
<term>Sprouty</term>
<term>Sprouty2</term>
<term>Spry2</term>
<term>Spry2 expression</term>
<term>Spry2 gene</term>
<term>Spry2 mrna</term>
<term>Spry2 protein</term>
<term>Spry2 transcription</term>
<term>Time course</term>
<term>Transcription</term>
<term>Transcriptional</term>
<term>Transcriptional repression</term>
<term>Transfected</term>
<term>Ubiquitination</term>
<term>Wong</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Mammalian Sprouty2 (Spry2) is a key regulator of the receptor tyrosine kinase/ERK signaling pathway and is involved in many biological processes, including cell growth, differentiation, migration, and embryonic lung branching morphogenesis. Previous studies have shown that Spry2 expression is upregulated by many mitogens, particularly epidermal growth factor (EGF) and fibroblast growth factors (FGFs). In contrast, we report that transforming growth factor‐β1 (TGF‐β1), which stimulates the growth of quiescent Swiss 3T3 cells, induced a dose dependent decrease of mouse Spry2 protein level within 24‐h of treatment, and this effect was mediated by a MAP kinase‐independent pathway. A concomitant reduction of the level of Spry2 mRNA indicates the involvement of a transcriptional mechanism, which requires histone deacetylase (HDAC) activity and de novo protein synthesis. On the other hand, the turnover rate of Spry2 protein was increased by TGF‐β1 treatment, suggesting enhanced Spry2 degradation. Treatment with lysosomal inhibitors, but not proteasome inhibitors, prevented the degradation of Spry2, thus, indicating that the degradation of Spry2 is mediated through the lysosomal pathway in Swiss 3T3 cells. Furthermore, we demonstrate that TGF‐β1 signaling can modulate EGF and FGF‐induced ERK‐MAP kinase activation by controlling Spry2 expression and function. Moreover, rescue of the TGF‐β1‐induced downregulation of Spry2 by gene over‐expression led to inhibition of the mitogenic effect of TGF‐β1 in Swiss 3T3 cells. Together, the combined operation of transcriptional and post‐translational mechanisms suggests that regulation of Spry2 is a crucial event and emphasizes the important role that Spry2 plays in controlling cell behaviors. J. Cell. Physiol. 212:796–806, 2007. © 2007 Wiley‐Liss, Inc.</div>
</front>
</TEI>
<affiliations>
<list>
<country>
<li>États-Unis</li>
</country>
<region>
<li>Californie</li>
</region>
</list>
<tree>
<country name="États-Unis">
<region name="Californie">
<name sortKey="Ding, Wei" sort="Ding, Wei" uniqKey="Ding W" first="Wei" last="Ding">Wei Ding</name>
</region>
<name sortKey="Bellusci, Saverio" sort="Bellusci, Saverio" uniqKey="Bellusci S" first="Saverio" last="Bellusci">Saverio Bellusci</name>
<name sortKey="Ding, Wei" sort="Ding, Wei" uniqKey="Ding W" first="Wei" last="Ding">Wei Ding</name>
<name sortKey="Ding, Wei" sort="Ding, Wei" uniqKey="Ding W" first="Wei" last="Ding">Wei Ding</name>
<name sortKey="Groffen, John" sort="Groffen, John" uniqKey="Groffen J" first="John" last="Groffen">John Groffen</name>
<name sortKey="Heisterkamp, Nora" sort="Heisterkamp, Nora" uniqKey="Heisterkamp N" first="Nora" last="Heisterkamp">Nora Heisterkamp</name>
<name sortKey="Minoo, Parviz" sort="Minoo, Parviz" uniqKey="Minoo P" first="Parviz" last="Minoo">Parviz Minoo</name>
<name sortKey="Shi, Wei" sort="Shi, Wei" uniqKey="Shi W" first="Wei" last="Shi">Wei Shi</name>
<name sortKey="Warburton, David" sort="Warburton, David" uniqKey="Warburton D" first="David" last="Warburton">David Warburton</name>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/ChloroquineV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001A99 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 001A99 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    ChloroquineV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     ISTEX:65538A0A8C504C9FFED9A73A517B79281A888132
   |texte=   Sprouty2 downregulation plays a pivotal role in mediating crosstalk between TGF‐β1 signaling and EGF as well as FGF receptor tyrosine kinase‐ERK pathways in mesenchymal cells
}}

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Wed Mar 25 22:43:59 2020. Site generation: Sun Jan 31 12:44:45 2021